Impact of Delayed Neoadjuvant Systemic Chemotherapy on Overall Survival Among Patients with Breast Cancer

BACKGROUND: Delays in the initiation of therapy among patients with early stage breast cancer (BC) can negatively affect outcomes. Patients treated with neoadjuvant systemic chemotherapy (NSC) usually display tumors with high‐risk features. Considering these high‐risk characteristics and the evidenc...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncologist
Hoofdauteurs: de Melo Gagliato, Debora, Lei, Xiudong, Giordano, Sharon H., Valero, Vicente, Barcenas, Carlos H., Hortobagyi, Gabriel N., Chavez‐MacGregor, Mariana
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley & Sons, Inc. 2020
Onderwerpen:
Breast Cancer
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485349/
https://ncbi.nlm.nih.gov/pubmed/32431013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0744
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items